Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Boston Scientific Corporation
  6. Summary
    BSX   US1011371077

BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
42.14(c) 42.02(c) 42.33(c) 42.84(c) 42.91(c) Last
7 467 356 4 840 199 3 863 518 3 992 009 5 347 059 Volume
+0.26% -0.28% +0.74% +1.20% +0.16% Change
More quotes
Financials (USD)
Sales 2021 11 758 M - -
Net income 2021 1 490 M - -
Net Debt 2021 5 912 M - -
P/E ratio 2021 42,9x
Yield 2021 -
Sales 2022 12 727 M - -
Net income 2022 1 826 M - -
Net Debt 2022 3 783 M - -
P/E ratio 2022 33,5x
Yield 2022 -
Capitalization 60 971 M 60 971 M -
EV / Sales 2021 5,69x
EV / Sales 2022 5,09x
Nbr of Employees 38 000
Free-Float 84,2%
More Financials
Company
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm... 
Read more
More about the company
Ratings of Boston Scientific Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about BOSTON SCIENTIFIC CORPORATION
06/07BOSTON SCIENTIFIC  : Argus Adjusts Boston Scientific's Price Target to $50 From ..
MT
06/03BOSTON SCIENTIFIC  : Insider Sales at Boston Scientific (BSX) are Significant an..
MT
06/02INSIDER TRENDS : Insider Adds to Selling Trend at Boston Scientific
MT
06/02INSIDER TRENDS : Boston Scientific Insider Extends 90-Day Selling Trend
MT
05/26SECTOR UPDATE : Health Care Stocks Slipping Ahead of Close
MT
05/26BOSTON SCIENTIFIC  : Needham Downgrades Boston Scientific to Hold From Buy, Expe..
MT
05/25BOSTON SCIENTIFIC  : Barclays Starts Boston Scientific at Overweight with $51 Pr..
MT
05/25BOSTON SCIENTIFIC  : Completes CE Mark for EXALT™ Model B Single-Use Bronc..
PR
05/24BOSTON SCIENTIFIC  : to Participate in Bernstein's 37th Annual Strategic Decisio..
PR
05/21BOSTON SCIENTIFIC  : Helping India, Brazil and Other Countries Fight Surges in C..
PU
05/21BOSTON SCIENTIFIC  : Her Determination in the Service of Others
PU
05/18BOSTON SCIENTIFIC  : Late-Breaking Registry Data at EuroPCR Congress Demonstrate..
PR
05/17BOSTON SCIENTIFIC  : ELEGANCE Patient Registry Focuses on Women and People of Co..
PU
05/14BOSTON SCIENTIFIC INVESTIGATION INIT : Kahn Swick & Foti, LLC Investigates the O..
BU
05/13BOSTON SCIENTIFIC CORP  : Entry into a Material Definitive Agreement, Terminatio..
AQ
More news
News in other languages on BOSTON SCIENTIFIC CORPORATION
04/28Tagesvorschau International
04/28TAGESVORSCHAU : Termine am 28. April 2021
03/29CAROTTE & BÂTON  : comment l'Arabie saoudite attire-t-elle les entreprises sur s..
02/03Morning Briefing - International
02/03TAGESVORSCHAU : Termine am 03. Februar 2021
More news
Analyst Recommendations on BOSTON SCIENTIFIC CORPORATION
More recommendations
Analysis
Analysis: With stick and carrot, Saudi starts winning over firms in regional race
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 32
Average target price 48,98 $
Last Close Price 42,91 $
Spread / Highest target 21,2%
Spread / Average Target 14,1%
Spread / Lowest Target -4,45%
EPS Revisions
Managers and Directors
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Jodi Eddy SVP, Chief Information & Digital Officer
Edward F. Mackey Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION19.36%60 971
THERMO FISHER SCIENTIFIC-0.14%182 817
DANAHER CORPORATION11.20%176 194
INTUITIVE SURGICAL, INC.5.64%102 341
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.10.33%89 297
ILLUMINA, INC.22.48%66 163